Mental retardation Smith Fineman Myers type
Mental Retardation Smith Fineman Myers Type[edit | edit source]
Mental Retardation Smith Fineman Myers Type, also known as Smith-Fineman-Myers syndrome, is a rare genetic disorder characterized by intellectual disability and distinct facial features. This condition is part of a group of disorders known as X-linked intellectual disability.
History[edit | edit source]
The syndrome was first described by Smith, Fineman, and Myers in 1980. It is named after these researchers who identified the unique combination of symptoms in affected individuals.
Genetics[edit | edit source]
Smith-Fineman-Myers syndrome is caused by mutations in the PHF6 gene, which is located on the X chromosome. This gene is responsible for encoding a protein involved in chromatin remodeling, which is crucial for regulating gene expression.
Symptoms[edit | edit source]
Individuals with this syndrome typically exhibit:
- Intellectual disability, ranging from mild to severe.
- Distinctive facial features, including a broad forehead, deep-set eyes, and a wide mouth.
- Short stature and skeletal anomalies.
- Behavioral issues, such as hyperactivity or autistic-like behaviors.
Diagnosis[edit | edit source]
Diagnosis of Smith-Fineman-Myers syndrome is based on clinical evaluation, family history, and genetic testing to identify mutations in the PHF6 gene. Genetic counseling is recommended for families with a history of the disorder.
Treatment[edit | edit source]
There is no cure for Smith-Fineman-Myers syndrome. Treatment focuses on managing symptoms and may include:
- Special education programs to address learning disabilities.
- Behavioral therapy to manage behavioral issues.
- Regular medical check-ups to monitor growth and development.
Prognosis[edit | edit source]
The prognosis for individuals with Smith-Fineman-Myers syndrome varies depending on the severity of symptoms. With appropriate support and interventions, many individuals can lead fulfilling lives.
Research[edit | edit source]
Ongoing research aims to better understand the genetic mechanisms underlying Smith-Fineman-Myers syndrome and to develop targeted therapies. Advances in gene therapy and personalized medicine hold promise for future treatments.
See Also[edit | edit source]
==
NIH genetic and rare disease info[edit source]
Mental retardation Smith Fineman Myers type is a rare disease.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD